💰 Financial Performance

Revenue Growth by Segment

Not disclosed in available documents.

Geographic Revenue Split

Not disclosed in available documents, though the company engages in international trade primarily in USD and Euro.

Profitability Margins

Not disclosed in available documents.

EBITDA Margin

Not disclosed in available documents.

Capital Expenditure

Not disclosed in available documents.

Credit Rating & Borrowing

The company last obtained a credit rating in 2014; no fresh credit rating was obtained for debt instruments or fund mobilization in FY 2023-24.

⚙️ Operational Drivers

Raw Materials

Raw materials (unspecified) are imported for a few products, but specific names and cost percentages are not disclosed.

Import Sources

Not disclosed in available documents.

Key Suppliers

Not disclosed in available documents.

Capacity Expansion

Not disclosed in available documents.

Raw Material Costs

Not disclosed in available documents.

Manufacturing Efficiency

Not disclosed in available documents.

Logistics & Distribution

Not disclosed in available documents.

📈 Strategic Growth

Expected Growth Rate

Not disclosed in available documents.

Growth Strategy

Not disclosed in available documents.

Products & Services

Finished goods (pharmaceutical formulations) and raw materials for specific products.

Brand Portfolio

Not disclosed in available documents.

New Products/Services

Not disclosed in available documents.

Market Expansion

Not disclosed in available documents.

Market Share & Ranking

Not disclosed in available documents.

Strategic Alliances

Not disclosed in available documents.

🌍 External Factors

Industry Trends

The company operates in the pharmaceutical sector (Formulations & Development). The industry is evolving toward stricter compliance with Indian Accounting Standards (Ind-AS), which the company adopted on April 1, 2017.

Competitive Landscape

Not disclosed in available documents.

Competitive Moat

Not disclosed in available documents.

Macro Economic Sensitivity

Not disclosed in available documents.

Consumer Behavior

Not disclosed in available documents.

Geopolitical Risks

Exposure to international trade in USD and Euro makes the company sensitive to global currency stability.

⚖️ Regulatory & Governance

Industry Regulations

The company must comply with SEBI (LODR) Regulations 2015 and Indian Accounting Standards (Ind-AS). It is subject to secretarial audits and reconciliation of share capital audits.

Environmental Compliance

Not disclosed in available documents.

Taxation Policy Impact

Not disclosed in available documents.

Legal Contingencies

NSE and BSE imposed a fine of INR 5,000 each (INR 10,000 total) for a delay in submitting related party disclosures for the half-year ended March 2022. No other penalties or strictures were imposed by statutory authorities in the last 3 years.

⚠️ Risk Analysis

Key Uncertainties

Foreign exchange risk due to international trade in USD and Euro. Market price volatility is evident as the stock price ranged from a low of INR 7.05 to a high of INR 24.29 during FY 2023-24.

Geographic Concentration Risk

Not disclosed in available documents.

Third Party Dependencies

Not disclosed in available documents.

Technology Obsolescence Risk

Not disclosed in available documents.

Credit & Counterparty Risk

Not disclosed in available documents.